Anthony Radford

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.

Boston Heart Diagnostics Corp. provides cardiovascular disease clinical services. It specializes in diagnostic testing, personalized treatment recommendations and personalized wellness programs. The company was founded by Bela F. Asztalos and Ernst J. Schaefer in 2007 and is headquartered in Framingham, MA.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA.

Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA.

CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018.

MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia.

Australis Biosciences operates as a boutique corporate advisory practice specializing in strategic advice. The firm serves in the area of healthcare, biotechnology and technology fields. The company is headquartered in Kew, Australia.

APAF Ltd. provides proteomic services. The non-profit company is based in Sydney, Australia.

Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA.

Rarecells USA, Inc. is a company dedicated to early cancer detection to save lives. The company is based in New York, NY. The company believes that accurate and early cancer detection has the potential to save millions of lives. Rarecells is developing a prostate cancer test and a multi-cancer test for early cancer diagnosis. The company is currently conducting three clinical studies to evaluate the performance of their dedicated iset-based assay. The company was founded in 2011 by Patrizia Paterlini-Bréchot, who has been the CEO since 2011.

Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019.

Part of Danaher Corp., Beckman Coulter Australia Pty Ltd. is an Australian company that manufactures and distributes clinical laboratory equipment. The company is based in Gladesville, Australia.

Prospection Pty Ltd. engages in the provision of a software as a service based analytics platforms. Its products and services include PharmDash, PharmMap, and Prospection Labs. The company was founded by Eric Chung, Ricky Chen, and Peter Cronin in 2012 and is headquartered in Haymarket, Australia.

Kinetic Diagnostics, Inc. provides precision medicine for athletes and fitness. The company was founded by James Valentine and Trisha Brown and is headquartered in Berkeley, CA.

IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA.

Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA.

Roswell Biotechnologies, Inc. is a company that is digitizing biology with molecular electronics to diagnose and treat diseases. The company has developed the world's first molecular electronics chip, the Roswell ME Chip™, which reads all molecules of life and provides direct real-time electrical detection of single-molecule events on-chip. The company's platform technology reduces the cost and complexity of DNA sequencing to address large markets in infectious disease surveillance and containment, precision medicine, molecular diagnostics, and DNA digital data storage. Roswell Biotechnologies was founded in 2014 by leaders in DNA sequencing and is headquartered in San Diego, CA. The company was founded by Mola Paul and Barry Merriman, with Mola Paul serving as the CEO since 2014.

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.

Roche Sequencing Solutions, Inc. engages in providing personalized healthcare by creating diagnostics and treatments tailored to individual genetic and disease profiles. The firm's solutions include NGS Oncology Assays, sample collection, nucleic acid extraction and library preparation. The company is headquartered in Pleasanton, CA.

Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward.